2021
Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the Lung
Ramalingam S, Dinan M, Crawford J. Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the Lung. Clinical Lung Cancer 2021, 22: e646-e653. PMID: 33582071, DOI: 10.1016/j.cllc.2020.12.013.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerMetastatic non-small cell lung cancerCommunity-based centersAcademic centersMetastatic non-small cell carcinomaNon-small cell carcinomaStudy periodPrimary end pointNational Cancer DatabaseCell lung cancerSquamous cell carcinomaCancer-related deathMost cancer-related deathsTreatment-related improvementOverall survivalSurvival gapSurvival disparitiesImproved survivalCell carcinomaLung cancerCancer DatabaseRetrospective analysisNew therapiesPatientsEnd point
2018
Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States
Ramalingam S, Dinan MA, Crawford J. Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States. Journal Of Thoracic Oncology 2018, 13: 1842-1850. PMID: 30312680, DOI: 10.1016/j.jtho.2018.09.007.Peer-Reviewed Original ResearchMeSH KeywordsAcademic Medical CentersAdenocarcinoma of LungAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Large CellCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCommunity Health CentersFemaleFollow-Up StudiesHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingRetrospective StudiesSurvival RateUnited StatesConceptsCommunity-based centersNational Cancer DatabaseSquamous cell carcinomaAcademic centersMetastatic NSCLCCell carcinomaLung cancerCancer DatabaseStage IV lung cancerSquamous cell lung cancerStage IV NSCLCPercentage of patientsYear of diagnosisCell lung cancerVariety of chemotherapyMultivariable regression modelsPrimary outcomeHistologic typeMultivariable analysisSignificant relative increasePrimary payerSurvival differencesSurvival comparisonsMultivariable modelTreatment strategies
2016
How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer
Robinson TJ, Thomas S, Dinan MA, Roman S, Sosa JA, Hyslop T. How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer. Journal Of Clinical Oncology 2016, 34: 3434-3439. PMID: 27528716, PMCID: PMC6366339, DOI: 10.1200/jco.2016.67.6437.Peer-Reviewed Original ResearchConceptsPapillary thyroid cancerOccult nodal diseaseLymph nodesThyroid cancerNodal diseaseTumor stageNumber of LNsProphylactic central neck dissectionAdjuvant radioactive iodineLymph node examinationIntermediate-risk diseaseNational Cancer DatabaseMore lymph nodesNode-positive diseasePathologic tumor stagePrimary tumor stageCentral neck dissectionLymph node yieldLN yieldAdult patientsLN evaluationNeck dissectionNodal positivityNode examinationOccult disease
2014
Treatment Patterns and Outcomes for Patients with Adrenocortical Carcinoma Associated with Hospital Case Volume in the United States
Gratian L, Pura J, Dinan M, Reed S, Scheri R, Roman S, Sosa JA. Treatment Patterns and Outcomes for Patients with Adrenocortical Carcinoma Associated with Hospital Case Volume in the United States. Annals Of Surgical Oncology 2014, 21: 3509-3514. PMID: 25069860, PMCID: PMC4515350, DOI: 10.1245/s10434-014-3931-z.Peer-Reviewed Original ResearchMeSH KeywordsAdrenal Cortex NeoplasmsAdrenocortical CarcinomaAdultAgedDatabases, FactualElective Surgical ProceduresFemaleFollow-Up StudiesHospitals, High-VolumeHospitals, Low-VolumeHumansLength of StayMaleMiddle AgedNeoplasm StagingOutcome and Process Assessment, Health CarePractice Patterns, Physicians'RegistriesReoperationSurvival RateWorkloadConceptsHigh-volume centersLow-volume centersHospital case volumeOverall survivalTreatment patternsCase volumeRegional lymph node evaluationAggressive surgical resectionLymph node evaluationPrimary adrenal malignancyMedian overall survivalNational Cancer DatabasePostoperative mortality rateBackgroundAdrenocortical carcinomaChemotherapy useAggressive treatmentRadical resectionReadmission ratesSurgical resectionAdrenal malignancyCarcinoma AssociatedClinical outcomesTumor characteristicsACC patientsAggressive diseaseRobotic Thyroidectomy for Cancer in the US: Patterns of Use and Short-Term Outcomes
Abdelgadir Adam M, Speicher P, Pura J, Dinan MA, Reed SD, Roman SA, Sosa JA. Robotic Thyroidectomy for Cancer in the US: Patterns of Use and Short-Term Outcomes. Annals Of Surgical Oncology 2014, 21: 3859-3864. PMID: 24934584, PMCID: PMC4519825, DOI: 10.1245/s10434-014-3838-8.Peer-Reviewed Original ResearchConceptsShort-term outcomesRobotic thyroidectomyMultivariable analysisOpen thyroidectomyOpen surgeryThyroid cancerPatterns of useRobotic casesRobotic groupRobotic surgeryThyroidectomy-specific complicationsUnderwent open surgeryNational Cancer DatabaseLong-term outcomesLength of stayMulti-institutional studyNon-significant increaseMore Asian patientsTotal thyroidectomyUnderwent lobectomyUnderwent thyroidectomyLymph nodesSurgery useAsian patientsPositive margins